Participating in JST Mirai Program Full-scale Research
The JST Mirai Program project “Accelerating Life Science through Robotic Biology” has been selected as a new full-scale research project for FY2020.
Research Overview
- Priority Theme: Realization of common platform systems and devices that create innovative knowledge and products
- Principal Investigator: Koichi Takahashi (Team Leader, BioFunction Science Research Center, RIKEN)
- Research Period: From December 2020 (Exploratory research period: November 2018 - November 2020)
- Details: https://www.jst.go.jp/mirai/jp/program/core/JPMJMI20G7.html
Our Role
As a collaborative research institution, we will provide technical expertise. Specifically, we are responsible for providing an automated protocol optimization system for establishing complex cell culture conditions, adapting the system to experimental robots, and supporting experimental protocol design and data management systems.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.